[Retracted] MicroRNA­874 is downregulated in cervical cancer and inhibits cancer progression by directly targeting ETS1.

Following the publication of this paper, it was drawn to the Editors' attention by a concerned reader that certain of the Transwell migration assay data shown in Fig. 3A were strikingly similar to data appearing in different form in other articles by different authors. Owing to the fact that the contentious data in the above article were already under consideration for publication prior to its submission to Oncology Reports, the Editor has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a satisfactory reply. The Editor apologizes to the readership for any inconvenience caused. [Oncology Reports 40: 2389­2398, 2018; DOI: 10.3892/or.2018.6624].

Association of thyroid function abnormality and prognosis in non-small-cell lung cancer patients treated with PD-1 inhibitors.

Background: Thyroid function abnormality (TFA) is one of the most common toxicities in non-small-cell lung cancer (NSCLC) patients receiving immune checkpoint inhibitors. However, the risk factors related to TFA and the relationship between TFA and prognosis in NSCLC are not fully clarified. Methods: We conducted a retrospective study of patients with advanced NSCLC who were treated with PD-1 inhibitors in Huzhou Central Hospital. Thyroid function test was carried out using electrochemiluminescent bridging immunoassay. The association between TFA and clinical outcome was investigated. Results: A total of 273 patients were included in this study. Patients who experienced TFA had longer progression-free survival (21.9 vs 6.4 months; p < 0.001) and overall survival (44.6 vs 24.1 months; p = 0.02) than patients without TFA. After multivariate analysis, TFA was an independent prognostic factor for progression-free and overall survival (p < 0.05). Conclusion: TFA is associated with better outcome in NSCLC patients who receive immunotherapy.

Many patients with non-small-cell lung cancer are treated with immunotherapy, a type of treatment that uses the body's natural immune system to fight diseases. We conducted a retrospective study of advanced non-small-cell lung cancer patients who were treated with PD-1 inhibitors (a type of immunotherapy) in Huzhou Central Hospital. Thyroid function abnormality (TFA) is one of the common toxicities in patients receiving PD-1 inhibitors. Our study showed that patients who experienced TFA have longer survival times compared with patients without TFA (overall survival, 44.6 vs 24.1 months; p = 0.02). TFA could be an effective predictor of outcome in non-small-cell lung cancer cases being treated with immunotherapy.

Collision carcinoma of endometrial adenocarcinoma and primary serous fallopian tube carcinoma: a case report.

Collision carcinoma is a rare malignancy that generally occurs in cervical, esophageal, pulmonary, and squamous cell cancers. Few studies have been reported involving endometrial adenocarcinoma and fallopian tube carcinoma. We reported the case of a 58-year-old woman who presented because of irregular vaginal bleeding for more than 1 month. Cervical biopsy suggested moderately differentiated cervical adenocarcinoma, and the patient underwent radical hysterectomy under general anesthesia. However, postoperative pathology and immunohistochemical results indicated a collision tumor comprising endometrial adenocarcinoma (grade I) and primary serous fallopian tube carcinoma. According to the treatment principle of multiple primary tumors, a regimen of paclitaxel combined with carboplatin was administered. The patient also underwent local pelvic radiotherapy to treat lymph node metastasis. One month later, the patient developed brain metastases and died.

Landscape Effects on the Abundance of Apolygus lucorum in Cotton Fields.

Resource-continuity over spatial and temporal scales plays a central role in the population abundance of polyphagous pests in an agricultural landscape. Shifts in the agricultural land use in a region may alter the configuration of key resource habitats, resulting in drastic changes in pest abundance. Apolygus lucorum (Meyer-Dür) (Hemiptera: Miridae) is a pest of cotton in northern China that has become more serious in recent years following changes in the region's cropping systems. However, no evidence from the landscape perspective has yet been gathered to account for the increasing population of A. lucorum in China. In this study, we investigated the effects of landscape composition on the population abundance of A. lucorum in cotton fields in July and August of 2016, respectively. We found that increased acreage planted to cotton actually had a negative effect on the abundance of A. lucorum, while planting of other crops (e.g., vegetables, soybean, and peanut) was positively associated with the mirid's population abundance in cotton fields. Maize production only displayed a positive effect on population abundance in August. Our results suggested that the decreasing of cotton area may weaken the trap-kill effect on A. lucorum, and the extension of other crops and maize potentially enhance the continuity of resources needed by A. lucorum. Combined effects of these two aspects may promote an increased population density of A. lucorum in the agriculture district. In the future, when possible, management strategies in key regional crops should be coordinated to reduce resource continuity at the landscape or area-wide scale to lower A. lucorum populations across multiple crops.

MicroRNA­874 is downregulated in cervical cancer and inhibits cancer progression by directly targeting ETS1.

An increasing number of studies have reported that microRNAs (miRNAs) are dysregulated in cervical cancer and serve critical roles in cervical oncogenesis and progression. Therefore, identifying the aberrantly expressed miRNAs implicated in the formation and progression of cervical cancer may provide key clues for the development of effective therapeutic targets in treating patients with this type of malignancy. In the present study, miRNA­874 (miR­874) was downregulated in cervical cancer tissues and cell lines, and this downregulation was associated with International Federation of Gynaecology and Obstetrics stage and lymph node metastasis. The restored expression of miR­874 prohibited the proliferation, migration and invasion, but promoted the apoptosis of cervical cancer cells. In addition, E26 transformation specific­1 (ETS1) was identified as the direct target of miR­874 in cervical cancer. Inhibition of ETS1 served tumour­suppressive roles similar to miR­874 overexpression in cervical cancer cells. A series of rescue experiments revealed that restoring ETS1 expression abolished the tumour­suppressing effects of miR­874 in cervical cancer cells. Taken together, the results of the present study indicated that miR­874 may serve as a tumour suppressor in cervical cancer by directly targeting ETS1. This function suggested that miR­874 holds potential therapeutic applications in treating patients with this type of malignancy.